';
CLOSE
Substance Use Disorder

0 1436
Folders with the label Applications and Grants

FOR IMMEDIATE RELEASE
July 16, 2020
View Online 

Harrisburg, PA – Today, Governor Tom Wolf announced the availability of $50 million in grant funding to help employers provide hazard pay to employees in life-sustaining occupations during the COVID-19 pandemic. Hazard pay is intended to keep front-line employees working in vital industry sectors across Pennsylvania.

“In the fight against COVID-19, our front-line workers have put themselves at risk every day in order to continue to provide life-sustaining services to their fellow Pennsylvanians, and this funding will increase their pay in recognition of those sacrifices,” said Gov. Wolf. “These grants will help businesses retain employees, ensure that Pennsylvanians keep working and avoid disruption of critical goods and services.”

Created through the federal Coronavirus Aid, Relief, and Economic Security (CARES) Act, this reimbursement-based grant is available to employers offering hazard pay during the eligible program period and will be administered by the Department of Community and Economic Development (DCED). Businesses may apply for grants up to a maximum of $3 million.

The following applicants are eligible to apply:

  • Businesses
  • Healthcare Non-profits
  • Public Transportation Agencies
  • Certified Economic Development Organizations (CEDO)

Eligible Pennsylvania-based industries include:

  • Healthcare and Social Assistance
  • Ambulatory Health Care Services
  • Hospitals
  • Nursing and Residential Care Facilities
  • Transit and Ground Passenger Transportation
  • Food Manufacturing
  • Food Retail Facilities
  • Security Services for eligible industries listed above and commercial industries that were not closed as a result of the Governor’s Business Closure Order
  • Janitorial Services to Buildings and Dwellings

Grant funds may be used for hazard pay for direct, full-time and part-time employees earning less than $20/hour, excluding fringe benefits and overtime for the 10-week period from August 16, 2020, to October 24, 2020. Applicants may apply for up to $1,200 per eligible full-time equivalent (FTE) employee. Employers may apply for a grant to provide hazard pay for up to 500 eligible full-time equivalent employees per location.

Eligible applicants may apply for grants using the online DCED Electronic Single Application for Assistance located at www.esa.dced.state.pa.us from July 16, 2020, to July 31, 2020. Program inquiries may be directed to (717) 787-6245 or [email protected].

“An essential component of the spending plan we passed this spring was the use of available federal money to provide extra hazard pay for workers who are doing the most dangerous jobs,” said House Democratic Leader Frank Dermody (D- Allegheny, Westmoreland). “Today’s announcement shows we are serious about keeping that commitment and I urge all the employers who qualify for these grants to apply now.”

“Front-line workers in many workplaces have been praised during this pandemic, including thousands of transit workers who drive, clean and maintain our buses and trains,” said state Rep. Mike Carrol (D- Lackawanna, Luzerne), Democratic chairman of the House Transportation Committee. “They’ve earned more than just good words. They deserve better pay for the risky work that they are continuing to do every day.”

“This grant program will put $50 million in CARES Act dollars into the pockets of Pennsylvania’s lowest-paid front-line workers, who risked their families’ health and safety to keep us fed, care for our children and elderly, and help fellow front-line workers get to and from work,” said state Sen. Maria Collett (D- Bucks, Montgomery), Democratic chairwoman of the Senate Aging and Youth Committee. “I am especially glad to see that Governor Wolf and DCED considered my input and included actual risk and local prevalence of COVID as evaluation criteria.”

“Front-line essential workers are the backbone of our economy, and they have been working in dangerous, sometimes deadly, conditions. They are putting themselves and their families at risk from COVID-19 on a daily basis and their wages should reflect that risk,” said state Sen. Lindsey Williams (D-Allegheny), Democratic chairwoman of the Senate Community, Economic and Recreational Development Committee. “Many of these workers didn’t sign up for life-threatening work, so I’m pleased that the Hazard Pay Grant Program will assist employers in compensating them more fairly for the newfound dangers that they face.”

For the most up-to-date information on COVID-19, Pennsylvanians should follow https://www.pa.gov/guides/responding-to-covid-19/.

MEDIA CONTACTS: Lyndsay Kensinger, Governor’s Office, [email protected]
Casey Smith, DCED, [email protected]

# # #

0 802

FOR IMMEDIATE RELEASE
July 16, 2020

Harrisburg, PA – Today, Governor Tom Wolf announced the availability of $10 million in grant funding through the COVID-19 Vaccines, Treatments, and Therapies (CV-VTT) program to support the rapid advancement of vaccines, treatments, and therapies by qualified biotechnology entities in response to the COVID-19 pandemic.

This funding was appropriated from the Act 2A of 2020, known as the COVID-19 Emergency Supplement to the General Appropriation Act of 2019, to the Pennsylvania Department of Health (DOH), to be administered through a Notice of Subgrant by the Pennsylvania Department of Community and Economic Development’s (DCED) Office of Technology and Innovation.

“Our commonwealth is home to some of the most brilliant minds and institutions and has a history of being a leader in developing groundbreaking science and advancing new, life-sustaining technologies,” said Gov. Wolf. “As we continue to take mitigation efforts seriously, we want to support groups that can move Pennsylvania forward in the development of treatments that can halt the spread of COVID-19 and protect our families, friends, and communities for the long-term.”

This program is available to Pennsylvania-based entities that demonstrate both a financial need and a well-defined pathway to the accelerated commercialization of a new vaccine, treatment, or therapy in direct response to the fight against COVID-19.

The following applicants are eligible to apply:

  • Colleges and universities
  • For-profit companies
  • Academic medical centers
  • Non-profit research institutions
  • Economic development organizations

Eligible applicants may apply for grants and learn more about the CV-VTT program here. The application deadline is Friday, July 24, 2020.

For the most up-to-date information on COVID-19, Pennsylvanians should follow https://www.pa.gov/guides/responding-to-covid-19/.

MEDIA CONTACTS:
Lyndsay Kensinger, Governor’s Office, [email protected]
Casey Smith, DCED, [email protected]

# # #

0 1441

FOR IMMEDIATE RELEASE
July 16, 2020

Harrisburg, PA – The Wolf Administration today announced that the Department of Human Services (DHS) will allow for additional Medicaid providers to enroll as an opioid use disorder Center of Excellence (COE). Since 2016, 45 COEs have transformed the way care is provided to people with opioid use disorder and have helped more than 30,000 Pennsylvanians access comprehensive, whole-person treatment that makes recovery possible.

“Connecting people to treatment that addresses both their opioid use disorder as well as physical and behavioral health needs is critical in saving lives and fighting the opioid epidemic,” said Governor Tom Wolf. “Centers of Excellence have proven themselves to be a critical part of our efforts to improve treatment options. By taking the next step in sustaining this program, individuals with opioid use disorder will have more access to treatment in their communities.”

DHS has announced a process for providers to enroll in the commonwealth’s Medicaid program as a COE specialty type provider. Providers who bear this specialty designation will be eligible to bill MCOs for care management services. This will allow DHS to continue to hold COEs to elevated standards by ensuring fidelity to the COE care model while also allowing other qualified providers to attain the distinction of COE.

“DHS is proud to oversee the development of the COE program, and we remain committed to helping the people at the center of this crisis,” said DHS Secretary Teresa Miller. “COEs are on the front lines in the fight against the opioid epidemic, and we want to be sure we are doing everything we can to support them. In continuing the program, DHS is taking the next step to cement the COE model as a standard of care for people with opioid use disorder.”

The COE program was established in 2016 through grants awarded to 45 providers throughout the commonwealth in order to increase access to medication assisted treatment, improve coordination of behavioral and physical healthcare for patients, and use community-based care management teams to keep people engaged in treatment across the continuum of care toward recovery.

COEs are designed to take care of the whole person by incorporating opioid use disorder treatment with physical, mental, and behavioral health treatment, as well as recovery support services. COEs use a blend of licensed and unlicensed, clinical and non-clinical staff to coordinate the care needs of an individual to ensure that their treatment and non-treatment needs are met.

The COEs’ care managers work to keep people with an opioid use disorder engaged in treatment by coordinating follow-up care and community supports that are vital to maintaining recovery. COEs work as a hub-and-spoke network, with the designated center serving as the hub. The spokes can include primary care practices, the criminal justice system, emergency departments, social services providers, other treatment providers, and other referral sources.

A study by the University of Pittsburgh found that COEs save lives by increasing access to medication assisted treatment and keeping people engaged in that treatment. Before receiving services from a COE, 46 percent of patients received medication assisted treatment, but after receiving COE services, nearly 73 percent of those patients were receiving treatment. The study also found that people who receive services from a COE are less likely to be admitted to the emergency room or the hospital due to an overdose. There is also a significant difference in how long a patient stays engaged in treatment; those who receive services from a COE stay in treatment longer than those who do not.

Applications for Medicaid providers to be enrolled as a COE may be submitted any time. Beginning January 1, 2021, only providers with the COE specialty type will receive payment for COE-type care management services. More information and the application for Medicaid providers to become a COE can be found here.

MEDIA CONTACT: Erin James, [email protected]

# # #

0 1242

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced additional distributions from the Provider Relief Fund to eligible Medicaid and Children’s Health Insurance Program (CHIP) providers that participate in state Medicaid and CHIP programs. HHS expects to distribute approximately $15 billion to eligible providers that participate in state Medicaid and CHIP programs and have not received a payment from the Provider Relief Fund General Allocation.  The deadline to submit the application to HRSA for this funding is July 20, 2020.

Eligibility Requirements:

To be eligible to receive HHS’ Medicaid Provider Distribution payments, initial key eligibility requirements for Medicaid and CHIP programs and/or Medicaid and CHIP managed care organization providers include:

  • The provider must not have received payments from the $50 billion Provider Relief Fund General Distribution to Medicare providers (note: if a Medicaid/CHIP provider was eligible for the General Distribution payment and rejected the payment, it cannot be eligible for the Medicaid Provider Distribution);
  • The provider must have directly billed or own (on the application date) an included subsidiary that has billed a state Medicaid/CHIP program and/or a Medicaid/CHIP managed care plan for health care-related services between January 1, 2018 and December 31, 2019;
  • The provider must have either (i) filed a federal income tax return for fiscal years 2017, 2018 or 2019 or (ii) be an entity exempt from the requirement to file a federal income tax return and have no beneficial owner that is required to file a federal income tax return (e.g. a state-owned hospital or healthcare clinic);
  • The provider must have provided patient care after January 31, 2020;
  • The provider must not have permanently ceased providing patient care directly, or indirectly through included subsidiaries; and
  • If the applicant is an individual, they must have gross receipts or sales from providing patient care reported on Form 1040, Schedule C, Line 1, excluding income reported on a W-2 as a (statutory) employee.

Examples of types of Medicaid/CHIP providers that are eligible for these payments include pediatricians, obstetrician-gynecologists, dentists, opioid treatment and behavioral health providers, assisted living facilities, and other providers of home and community-based services. In order to receive Provider Relief Fund payments, eligible Medicaid/CHIP providers must take action through HRSA’s application portal and comply with the Medicaid Relief Fund Payment Terms and Conditions.

Provider Relief Fund payments will be at least two percent (2%) of reported gross revenue from patient care. Eligible Medicaid/CHIP providers can report their gross annual patient revenue through the Enhanced Provider Relief Fund Payment Portal and the final amount that a provider receives will be determined after such data is submitted, including information on the number of Medicaid patients served. HHS has issued a comprehensive set of instructions for submitting an application through the application portal.

Before applying through the Enhanced Provider Relief Fund Payment Portal, applicants should:

In addition, DHS encourages Medicaid/CHIP providers to carefully review the Medicaid Relief Fund Payment Terms and Conditions with their attorneys and accountants on the appropriate use of and questions about CARES Act Provider Relief Funds.

HHS has created a listing of CARES Act Provider Relief Funds Frequently Asked Questions (FAQ).

The complete press release is on the HHS website.

More information about eligibility and the application process is also available on the HHS website.

** Please note when applying for this, the first step is to enter your Tax ID Number.   The number must be verified before you can move to the next step.  This could take a day or two, therefore providers should NOT wait until the last day, July 20 to apply.

0 1398

The Substance Abuse and Mental Health Services Administration (SAMHSA), part of the U.S. Department of Health and Human Services (HHS or Department), announces the adoption of the revised Confidentiality of Substance Use Disorder Patient Records regulation, 42 CFR Part 2. The adoption of this revised rule represents a historic step in expanding care coordination and quality through the Deputy Secretary’s Regulatory Sprint to Coordinated Care.

“This reform will help make it easier for Americans to discuss substance use disorders with their doctors, seek treatment, and find the road to recovery,” said HHS Secretary Alex Azar. “President Trump has made the availability of treatment for Americans with substance use disorders, including opioid use disorder, a priority. Thanks to the valuable input of stakeholders, our final rule will make it easier for Americans to seek and receive treatment while lifting burdens on providers and maintaining important privacy protections.”

The new rule advances the integration of healthcare for individuals with substance use disorders while maintaining critical privacy and confidentiality protections. Under Part 2, a federally assisted substance use disorder program may only disclose patient identifying information with the individual’s written consent, as part of a court order, or under a few limited exceptions. Health care providers, with patients’ consent, will be able to more easily conduct such activities as quality improvement, claims management, patient safety, training, and program integrity efforts.

“Coordinated care is a vital piece of President Trump’s vision for a patient-centric healthcare system, and regulatory reform is a key step toward promoting more coordinated care,” said HHS Deputy Secretary Eric Hargan. “As part of our Regulatory Sprint to Coordinated Care, these changes are just the beginning of a comprehensive agenda for reforming regulations that govern the delivery and financing of American healthcare, with the ultimate goal of better care, and better health, at a lower cost.”

“The adoption of this rule means Americans will be better able to receive integrated and coordinated care in the treatment of their substance use disorders,” said HHS Assistant Secretary for Mental Health and Substance Use Elinore F. McCance-Katz, MD, PhD, the head of SAMHSA. “We are grateful to the individuals and organizations that contributed their input to the rule-making process. This is great news for our nation’s families and communities.”

“Modernizing 42 CFR Part 2 will strengthen the nation’s efforts to reduce opioid misuse and abuse and to support patients and their families confronting substance use disorders,” the Assistant Secretary said. “The rule will make it easier for primary care clinicians to treat individuals with substance use disorders.”

“We need an all-hands-on-deck approach to treating substance use disorders,” said McCance-Katz. “We must do all we can to ensure the greatest access and availability to care for individuals living with substance use disorders. Although well-intentioned, the non-disclosure of critical, lifesaving information the previous rule permitted is itself stigmatizing.”

The ease of sharing information, with patient consent, among providers will enable better, higher-quality care for those with substance use disorders. This serves as an important milestone in further aligning 42 CFR Part 2 and the Health Insurance Portability and Accountability Act of 1996 (or HIPAA) regulations.

To view a list of the changes in the final rule, please click here.

0 997

Recently, DDAP hosted live webinars on the alignment of services within the 3.0 levels of care (3.1, 3.5 & 3.7) with The ASAM Criteria, 2013. The recorded version of this presentation, along with the PowerPoint slides are now available on the ASAM Transition page on the DDAP website.

Questions regarding alignment of 3.0 services to the ASAM Criteria may be submitted by email for inclusion in WebEx Q&A sessions to be held on July 27 and July 28 (see Rollout Schedule on DDAP website) and an FAQ that will be made available around the same time.

Prev1...227228229...280Next Page 228 of 280
© 2021 - Rehabilitation & Community Providers Association